A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene that abolish the synthesis of dystrophin protein. Antisense oligonucleotides (AOs) targeted to trigger excision of an exon bearing a mutant premature stop codon in the DMD transcript have been shown to skip the mutated exon and...
Những tác giả chính: | Yin, H, Moulton, H, Betts, C, Seow, Y, Boutilier, J, Iverson, P, Wood, M |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2009
|
Những quyển sách tương tự
-
Functional rescue of dystrophin-deficient mdx mice by a chimeric peptide-PMO
Bằng: Yin, H, et al.
Được phát hành: (2010) -
Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice
Bằng: Gang Han, et al.
Được phát hành: (2016-03-01) -
Good news for the mdx mouse community: Improved dystrophin restoration after skipping mouse dystrophin exon 23
Bằng: Annemieke Aartsma-Rus
Được phát hành: (2022-12-01) -
Context dependent effects of chimeric peptide morpholino conjugates contribute to dystrophin exon-skipping efficiency
Bằng: Yin, HF, et al.
Được phát hành: (2016) -
Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment
Bằng: Betts, C, et al.
Được phát hành: (2018)